Citadel Advisors »

Silence Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.0M 439k 18.18
2024-06-30 $2.2M 117k 19.00
2024-03-31 $922k 43k 21.60
2023-12-31 $378k 22k 17.37
2022-06-30 $136k 11k 11.89

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Booking Holdings Call Option (BKNG)
Spdr Gold Tr Gold Shs Call Option (GLD)

View all positions for Citadel Advisors

Top funds holding Silence Therapeutics

TCG Crossover Management
Siren
Redmile Group
Logos Global Management
Deep Track Capital
Frazier Life Sciences Management
Nextech Invest
Henderson Group
Eventide Asset Management
Cormorant Asset Management
Ikarian Capital
5AM Venture Management
Point72 Asset Management
Citadel Advisors
Woodline Partners

View all funds holding Silence Therapeutics